Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2024 17:00 ET | Source: Precipio, Inc.

Precipio Secures a short-term $500K Credit Facility

NEW HAVEN, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces it has secured a short-term loan facility of $500K to deal with any...
March 25, 2024 17:00 ET | Source: Precipio, Inc.

Precipio Announces Year end 2023 Shareholder Update Call

NEW HAVEN, Conn., March 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its year end 2023 corporate update call on April 1st, 2024 at...
February 13, 2024 10:00 ET | Source: Precipio, Inc.

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

NEW HAVEN, Conn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that for the full year of 2023, its unaudited revenues have grown...
February 06, 2024 10:00 ET | Source: Precipio, Inc.

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into a distribution agreement with Cardinal Health for...
January 23, 2024 10:00 ET | Source: Precipio, Inc.

Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

NEW HAVEN, Conn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that continued revenue growth generated cash levels that bring the...
January 17, 2024 10:30 ET | Source: Precipio, Inc.

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

NEW HAVEN, Conn., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the...
January 02, 2024 09:00 ET | Source: Precipio, Inc.

Precipio Announces Christina Valauri joins the Board of Directors

NEW HAVEN, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is pleased to welcome Christina Valauri to its board of directors effective Jan...
December 14, 2023 16:30 ET | Source: Precipio, Inc.

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

NEW HAVEN, Conn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) shares thoughts and reflections looking back at 2023, and forward...
November 16, 2023 17:00 ET | Source: Precipio, Inc.

Precipio Announces Q3-2023 Shareholder Update Call

NEW HAVEN, Conn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2023 corporate update call on November 20th, 2023 at...
October 18, 2023 09:00 ET | Source: Precipio, Inc.

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

NEW HAVEN, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that Q3-2023 (unaudited) revenues have increased 28% to $4.5M from...